Browsing Tag
Insulet Corporation
5 posts
Is MiniMed (Nasdaq: MMED) worth watching after its IPO slide and before June earnings?
MiniMed (Nasdaq: MMED) is down from its IPO price. Read what June earnings, new product launches, and analyst targets could mean next.
MiniMed IPO: Medtronic (NYSE: MDT) to separate diabetes business with Nasdaq filing under MMED
Medtronic files IPO for MiniMed, its diabetes business. Find out what the Nasdaq listing means for the company’s strategy, margins, and the diabetes tech sector.
Insulet names Flavia Pease as new CFO while signaling stronger Q3 revenue growth momentum
Insulet (NASDAQ: PODD) taps Flavia Pease as CFO and expects Q3 revenue growth to surpass guidance. Find out what this means for investors and the medtech sector.
Insulet stock skyrockets 21% as Omnipod 5 drives global sales surge and upgraded 2025 forecast
Find out how Insulet’s Q1 2025 earnings and global Omnipod 5 expansion lifted its stock 21%—with a raised full-year outlook to match.
Regencell, Lyft, Insulet lead U.S. stock gainers amid biotech and tech surge
U.S. stock market gainers led by Regencell and Lyft defied macro headwinds. Explore full stock insights, policy impacts, and investor sentiment shifts.